USFDA APPLICATION NUMBER - 22160 / DOSAGE - INJECTABLE;INTRAVENOUS - 100MG/20ML (5MG/ML)
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
OXALIPLATIN(UNII: 04ZR38536J) (OXALIPLATIN - UNII:04ZR38536J) | OXALIPLATIN | 100mg in 20 | 50mg in 10 |
Inactive Ingredients
Ingredient Name | Actavis Pharma, Inc. | APP Pharmaceuticals, LLC | Alvogen Inc. | Athenex Pharmaceutical Division, LLC. | Aventis Pharma Ltd. | Baxter Healthcare Corporation | BluePoint Laboratories | Breckenridge Pharmaceutical, Inc. | Cipla USA Inc. | Mylan Institutional LLC | NorthStar RxLLC | Sandoz Inc. | Sanja Pharmaceuticals Company | sanofi-aventis U.S. LLC |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | ||||||||||||||
WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?